American Society for Gastrointestinal Endoscopy - European Society of Gastrointestinal Endoscopy guideline on primary endoscopic bariatric and metabolic therapies for adults with obesity
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F24%3A00084938" target="_blank" >RIV/00023001:_____/24:00084938 - isvavai.cz</a>
Výsledek na webu
<a href="https://www.giejournal.org/action/showPdf?pii=S0016-5107%2823%2903148-6" target="_blank" >https://www.giejournal.org/action/showPdf?pii=S0016-5107%2823%2903148-6</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.gie.2023.12.004" target="_blank" >10.1016/j.gie.2023.12.004</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
American Society for Gastrointestinal Endoscopy - European Society of Gastrointestinal Endoscopy guideline on primary endoscopic bariatric and metabolic therapies for adults with obesity
Popis výsledku v původním jazyce
This joint ASGE-ESGE guideline provides an evidence-based summary and recommendations regarding the role of endoscopic bariatric and metabolic therapies (EBMTs) in the management of obesity. The document was developed using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) framework. It evaluates the efficacy and safety of EBMT devices and procedures that currently have CE mark or FDA-clearance/approval, or that had been approved within five years of document development. The guideline suggests the use of EBMTs plus lifestyle modification in patients with a BMI of >= 30 kg/m(2), or with a BMI of 27.0-29.9 kg/m(2) with at least 1 obesity-related comorbidity. Furthermore, it suggests the utilization of intragastric balloons and devices for endoscopic gastric remodeling (EGR) in conjunction with lifestyle modification for this patient population.
Název v anglickém jazyce
American Society for Gastrointestinal Endoscopy - European Society of Gastrointestinal Endoscopy guideline on primary endoscopic bariatric and metabolic therapies for adults with obesity
Popis výsledku anglicky
This joint ASGE-ESGE guideline provides an evidence-based summary and recommendations regarding the role of endoscopic bariatric and metabolic therapies (EBMTs) in the management of obesity. The document was developed using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) framework. It evaluates the efficacy and safety of EBMT devices and procedures that currently have CE mark or FDA-clearance/approval, or that had been approved within five years of document development. The guideline suggests the use of EBMTs plus lifestyle modification in patients with a BMI of >= 30 kg/m(2), or with a BMI of 27.0-29.9 kg/m(2) with at least 1 obesity-related comorbidity. Furthermore, it suggests the utilization of intragastric balloons and devices for endoscopic gastric remodeling (EGR) in conjunction with lifestyle modification for this patient population.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
30219 - Gastroenterology and hepatology
Návaznosti výsledku
Projekt
—
Návaznosti
N - Vyzkumna aktivita podporovana z neverejnych zdroju
Ostatní
Rok uplatnění
2024
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Gastrointestinal endoscopy
ISSN
0016-5107
e-ISSN
1097-6779
Svazek periodika
99
Číslo periodika v rámci svazku
6
Stát vydavatele periodika
US - Spojené státy americké
Počet stran výsledku
83
Strana od-do
867-"885.e64"
Kód UT WoS článku
001250222200001
EID výsledku v databázi Scopus
2-s2.0-85192004059